The Body Covers:
The 7th Conference on Retroviruses and Opportunistic Infections
San Francisco Marriott, San Francisco, California
January 30 - February 2, 2000
The Retrovirus Conference, regarded as one of the most important scientific gatherings of the year, was created to provide a forum for scientists and clinicians to present, discuss, and critique developments in the field of human retrovirology and related opportunistic complications. The subjects that will be highlighted are: virology, pathogenesis, host-virus interactions, pathology, immunology, epidemiology, diagnostics, prevention, therapy, pharmacology, and vaccines. In addition, new scientific studies concerning the diagnosis, treatment, and prevention of associated opportunistic infections will be included.
Reporting exclusively for The Body are Alvan Fisher, M.D., Rhode Island Hospital and Associate Professor, Brown University School of Medicine; Ian Frank, M.D., Hospital of the University of Pennsylvania and Associate Professor, University of Pennsylvania; Mark Holodniy, M.D., Veterans Affairs Medical Center and Associate Professor, Stanford University; Paul E. Sax, M.D., Brigham and Women's Hospital (BWH) in Boston and Associate Professor, Harvard Medical School; and Rick Stryker, M.D., Pacific Oaks Medical Group, Los Angeles, CA; Melanie A. Thompson, M.D., AIDS Research Consortium of Atlanta; Doug Ward, M.D., Dupont Circle Physicians Group, Washington, D.C.
In addition, the Seattle Treatment Education Project (STEP), publisher of the treatment journal, STEP Perspective, will be providing additional conference summaries. STEP reporters include: Dan Dawson, Editor of the STEP Perspective.
Funding for this conference coverage at The Body is provided, in part, by unrestricted educational grants from Agouron Pharmaceuticals, Bristol-Myers Squibb, DuPont Pharmaceuticals Company, Glaxo Wellcome, and Roxane Laboratories.